
Signs of Precancerous Colon Conditions
Adenomatous polyps are a precancerous condition. They are not cancerous by themselves and are often largely harmless. Their presence, however, indicates abnormal changes to colon
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Colon cancer is among the most common cancers in the United States and is the third leading cause of cancer deaths. When treating colon cancer, determining the type is imperative. Most colon cancer cases are adenocarcinomas of the colon.
Many patients diagnosed with colon cancer seek care from Regional Cancer Care Associates (RCCA). RCCA is a group of more than 90 medical oncologists and hematologists who treat patients who have solid tumors, blood-based cancers and benign blood disorders at more than 20 locations throughout New Jersey, Connecticut, Massachusetts, and the Washington, DC area. They strive to educate patients while providing innovative care.
Adenocarcinomas of the colon are the most common type of colon cancer. They form from glandular cells located along the large intestine. These cells produce mucus, a gel-like fluid that helps stool move smoothly along the length of the colon. Mucus also acts as a protective barrier to shield the intestinal lining against bacteria and irritants. An adenocarcinoma forms when genetic changes cause gland cells to reproduce without restraint, creating a constantly growing mass of abnormal tissue.
Like other types of cancer, adenocarcinoma of the colon is staged based on the TNM system. This system combines the tumor’s size, its spread to nearby lymph nodes, and its degree of metastasis to categorize it into one of four stages:
Patient outlooks for Stage I colon cancer are very good, with a five-year relative survival rate of 91%. Once the cancer begins to spread, however, the outlook becomes much worse. The five-year relative survival rate for Stage III cancer is 73%, and for Stage IV cancer is 13%. This drop is why early detection is so important. The sooner treatment begins, the better chance a patient has of a long survival.
Because adenocarcinoma of the colon is the most common type of colon cancer, its symptoms are the most widely known. These symptoms typically develop slowly and are caused by the growing tumor obstructing the colon. Each person has a unique experience, but many may notice:
It is important to note that the great majority of women and men who experience one or more of the symptoms listed above will not have colon cancer. Many of these symptoms are more commonly caused by less serious conditions, such as bowel inflammation or food intolerances. Nonetheless, it is important to consult a physician about these symptoms, particularly if they are pronounced, arose suddenly, or have persisted for an extended period. Prompt evaluation will enable a doctor to address your concerns and to provide a treatment plan.
Most cases of colon cancer, including adenocarcinoma of the colon, are initially detected by a routine colon cancer screening test. If screening detects something suspicious, then doctors will perform additional tests to confirm the cause. Diagnosing colon cancer typically involves a series of tests, which may include:
After diagnosing adenocarcinoma of the colon, oncologists work with patients to determine the best treatment path. Treatment may feature one or more of the following approaches:
Surgery is the standard treatment for low-stage adenocarcinomas that have not spread significantly. The goal of surgical treatment is to remove all of the tumor. Some of the colon and nearby lymph nodes may also be removed to ensure that no cancer cells are left behind.
Radiation therapy kills cancer cells by targeting them with high-energy rays. It is often recommended for patients whose age or overall health would make surgery dangerous. Radiation therapy may also be used to shrink tumors before surgery or clean up cells that remain afterward.
Chemotherapy is a drug-based treatment that is highly toxic to cells that grow and divide quickly, including cancer cells. It works throughout the body, making it effective at controlling cancer that has spread beyond its origin. New chemotherapies are in development with fewer side effects.
Targeted therapies are the latest breakthrough in cancer treatment. They use molecular medicine to attack cells with specific characteristics, helping them eliminate cancer without damaging healthy tissue. Targeted therapies are often effective when other treatments fail.
Patients with adenocarcinoma of the colon can find state-of-the-art treatment in New Jersey, Connecticut, Massachusetts, and the Washington, D.C., area at Regional Cancer Care Associates. RCCA specialists provide care to more than 30,000 new patients and 265,000 established patients each year. RCCA physicians offer patients innovative therapies, including immunotherapies and targeted therapy, cutting-edge diagnostics as well as access to approximately 300 clinical trials in community-based centers close to home.
What causes colon cancer?
Colon cancer is caused by a DNA change in the cells of the colon. The reason for this change is not always clear, though it has been tied to risk factors including a person’s age, their diet and level of physical activity, a history of certain medical conditions, and genetic predispositions.
Can colon cancer be prevented?
Colon cancer cannot always be prevented, but patients can take active steps to reduce their risk of cancer. The best ways to reduce colon cancer risk are by eating a healthy diet, exercising frequently, avoiding heavy alcohol use, and quitting smoking.
Can colon cancer be asymptomatic?
Early stages of colon cancer often cause no symptoms at all. Symptoms only develop in later stages as the tumor grows larger and spreads farther. This can make colon cancer difficult to detect, making screening the most effective way of catching cancer early.
Are there newer treatments for colon cancer?
Yes, targeted therapy and immunotherapy are newer, innovative treatments that are especially effective for advanced or genetically specific cases.
What is the recurrence rate of colon cancer?
About 10%-30% of patients with colon cancer experience recurrence. However, the rate depends on the stage at diagnosis and the success of the treatment.
From the moment you have you first appointment at one of RCCA’s 25+ locations, you’ll experience quality care that only our highly trained oncologists can provide. We’ll take the time to help you understand your diagnosis and your options, so you and your doctor can devise the best treatment plan for your unique situation. You’ll also have access to clinical trials, putting you at the forefront of innovations in the field of colon cancer care.
To learn more about colon cancer treatment at RCCA or to schedule an appointment, reach out to us at 844-346-7222.

Adenomatous polyps are a precancerous condition. They are not cancerous by themselves and are often largely harmless. Their presence, however, indicates abnormal changes to colon

Colon cancer is among the most common cancer types diagnosed in the United States. According to colon cancer projections from the American Cancer Society, about

If you or a loved one has been diagnosed with colon cancer, identifying the treatment approach that’s best for you and your particular circumstances is
When standard cancer treatments aren’t providing the results you want, clinical trials may offer hope. Our physicians use clinical trials to study new treatments, helping transform cancer care for the better. You can enroll in a clinical trial to try groundbreaking treatment plans at zero cost to you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.